Affordable Access

Access to the full text

Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018

Authors
  • Mafi, John N.1, 2
  • Reid, Rachel O.3, 4, 5
  • Baseman, Lesley H.3
  • Hickey, Scot2
  • Totten, Mark2
  • Agniel, Denis2
  • Fendrick, A. Mark6, 7
  • Sarkisian, Catherine8, 9
  • Damberg, Cheryl L.2
  • 1 Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles
  • 2 RAND Health Care, RAND Corporation, Santa Monica, California
  • 3 RAND Health Care, RAND Corporation, Boston, Massachusetts
  • 4 Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Boston, Massachusetts
  • 5 Harvard Medical School, Harvard University, Boston, Massachusetts
  • 6 Department of Internal Medicine, University of Michigan, Ann Arbor
  • 7 Center for Value-Based Insurance Design, University of Michigan, Ann Arbor
  • 8 Division of Geriatrics, David Geffen School of Medicine at the University of California, Los Angeles
  • 9 Geriatric Research Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, California
Type
Published Article
Journal
JAMA Network Open
Publisher
American Medical Association
Publication Date
Feb 16, 2021
Volume
4
Issue
2
Identifiers
DOI: 10.1001/jamanetworkopen.2020.37328
PMID: 33591365
PMCID: PMC7887655
Source
PubMed Central
Disciplines
  • Health Policy
License
Green
External links

Abstract

Importance Low-value care, defined as care offering no net benefit in specific clinical scenarios, is associated with harmful outcomes in patients and wasteful spending. Despite a national education campaign and increasing attention on reducing health care waste, recent trends in low-value care delivery remain unknown. Objective To assess national trends in low-value care use and spending. Design, Setting, and Participants In this cross-sectional study, analyses of low-value care use and spending from 2014 to 2018 were conducted using 100% Medicare fee-for-service enrollment and claims data. Included individuals were aged 65 years or older and continuously enrolled in Medicare parts A, B, and D during each measurement year and the previous year. Data were analyzed from September 2019 through December 2020. Exposure Being enrolled in fee-for-service Medicare for a period of time, in years. Main Outcomes and Measures The Milliman MedInsight Health Waste Calculator was used to assess 32 claims-based measures of low-value care associated with Choosing Wisely recommendations and other professional guidelines. The calculator designates services as wasteful, likely wasteful, or not wasteful based on an absence of indication of appropriate use in the claims history; calculator-designated wasteful services were defined as low-value care. Spending was calculated as claim-line level (ie, spending on the low-value service) and claim level (ie, spending on the low-value service plus associated services), adjusting for inflation. Results Among 21 045 759 individuals with fee-for-service Medicare (mean [SD] age, 77.4 [7.9] years; 12 515 915 [59.5%] women), the percentage receiving any of 32 low-value services decreased from 36.3% (95% CI, 36.3%-36.4%) to 33.6% (95% CI, 33.6%-33.6%) from 2014 to 2018. Uses of low-value services per 1000 individuals decreased from 677.8 (95% CI, 676.2-679.5) to 632.7 (95% CI, 632.6-632.8) from 2014 to 2018. Three services comprised approximately two-thirds of uses among 32 low-value services per 1000 individuals: preoperative laboratory testing decreased from 213.8 (95% CI, 213.4-214.2) to 166.2 (95% CI, 166.2-166.2), while opioids for back pain increased from 154.4 (95% CI, 153.6-155.2) to 182.1 (95% CI, 182.1-182.1) and antibiotics for upper respiratory infections increased from 75.0 (95% CI, 75.0-75.1) to 82 (95% CI, 82.0-82.0). Spending per 1000 individuals on low-value care also decreased, from $52 765.5 (95% CI, $51 952.3-$53 578.6) to $46 921.7 (95% CI, $46 593.7-$47 249.7) at the claim-line level and from $160 070.4 (95% CI, $158 999.8-$161 141.0) to $144 741.1 (95% CI, $144 287.5-$145 194.7) at the claim level. Conclusions and Relevance This cross-sectional study found that among individuals with fee-for-service Medicare receiving any of 32 measured services, low-value care use and spending decreased marginally from 2014 to 2018, despite a national education campaign in collaboration with clinician specialty societies and increased attention on low-value care. While most use of low-value care came from 3 services, 1 of these was opioid prescriptions, which increased over time despite the harms associated with their use. These findings may represent several opportunities to prevent patient harm and lower spending.

Report this publication

Statistics

Seen <100 times